Amouyal Philippe

Amouyal Philippe is listed in filings as Director at Lexicon Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jun 4, 2026, including 7 public disclosures. Recent filings connect the profile to Lexicon Pharmaceuticals, Inc. (LXRX) and CAVA Group, Inc. (CAVA). The current snapshot covers public activity from May 13, 2025 to Jun 4, 2026. Reported amounts are shown as $70.0K to $64.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.